Impact of Race on Outcomes of Advanced Stage Non-Small Cell Lung Cancer Patients Receiving Immunotherapy

Background: The impact of race in advanced stage non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs) is conflicting. Our study sought to examine racial disparities in time to treatment initiation (TTI), overall survival (OS), and progression-free survival (PF...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasli, Melisa, Kannaiyan, Radhamani, Namireddy, Praveen, Walker, Paul, Muzaffar, Mahvish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136836/
https://www.ncbi.nlm.nih.gov/pubmed/37185434
http://dx.doi.org/10.3390/curroncol30040321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136836/
https://www.ncbi.nlm.nih.gov/pubmed/37185434
http://dx.doi.org/10.3390/curroncol30040321

Ejemplares similares